Phase 1 Diagnostic Tests

The Biosensor Platform uses Organic Thin Film Transistor (OTFT) technology, which can be printed at scale, at a low cost. By substituting the detection element (region A) depending on the analyte to be detected, the Biosensor can be modified to monitor a wide range of saliva-based diagnostic analytes . The Platform is in development to test for up to 130 indications, ranging from glucose to immunological conditions and communicable diseases.

Currently, we are developing two urgently needed innovations using the Biosensor Platform.

Future Pipeline

IMMUNOLOGY

The pilot diagnostic test will be SARS-CoV-2 and the portfolio will consist of various communicable disease tests including Hepatitis A, B & C, HIV and TORCH.

HORMONES

The first test to be developed from a hormone category is Luteinizing Hormone (LH).

BIOCHEMISTRY

The pilot diagnostic test is Saliva Glucose. Diagnostic test portfolio includes Clinical Chemistry Tests (ie. Cholesterol).

TUMOR MARKERS

Tumor markers can be used in guiding treatment decisions, monitoring treatment, predicting the chance of recovery, and predict or monitor for tumor recurrence.

BIOSENSOR PLATFORM

BIOCHEMISTRY

TUMOR MARKERS

IMMUNOLOGY

HORMONES

NUCLEIC ACIDS

DIAGNOSTIC TEST
PORTFOLIO
Clinical Chemistry Tests (i.e. Cholesterol)
Diagnostic and Staging Cancer Markers
– Clinical
– Immunology Tests
-TORCH
– HIV, AIDS,
– Hep A,B & C
– Thyroid
– Adrenal
– Pituitary
– Gyncecological
– Andrology
Personalized Genetic Diagnostics
PHASE 2
DIAGNOSTIC TEST
Prostate Specific Antigen (PSA)
Luteinizing Hormone (LH)
PHASE 1
DIAGNOSTIC TEST
Saliva Glucose Test
SARS-CoV-2 Antibodies

BIOSENSOR PLATFORM

DIAGNOSTIC TEST
PORTFOLIO

BIOCHEMISTRY

Clinical Chemistry Tests (i.e. Cholesterol)

TUMOR MARKERS

Diagnostic and Staging Cancer Markers

IMMUNOLOGY

– Clinical
– Immunology Tests
-TORCH
– HIV, AIDS,
– Hep A,B & C

HORMONES

– Thyroid
– Adrenal
– Pituitary
– Gyncecological
– Andrology

NUCLEIC ACIDS

Personalized Genetic Diagnostics

PHASE 2
DIAGNOSTIC TEST

BIOCHEMISTRY

TUMOR MARKERS

Prostate Specific Antigen (PSA)

IMMUNOLOGY

HORMONES

Luteinizing Hormone (LH)

NUCLEIC ACIDS

PHASE 1
DIAGNOSTIC TEST

BIOCHEMISTRY

Saliva Glucose Test

TUMOR MARKERS

IMMUNOLOGY

SARS-CoV-2 Antibodies

HORMONES

NUCLEIC ACIDS

SARS-COV-2 Antibody Biosensor

A non-invasive, real-time antibody test to monitor exposure, infection and immunity levels in the fight against COVID-19.

Sign Up

Register for email alerts for the latest on the Biosensor Platform and GBS Inc.

  • This field is for validation purposes and should be left unchanged.